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Objectives . The present study evaluated our experience with
coronary artery bypass grafting in patients with severe left
ventricular dysfunction.
Background. Despite the ominous prognosis of advanced isch-
emic cardiomyopathy, coronary artery bypass grafting in this
setting remains controversial because of concerns over operative
risk and lack of functional or survival benefit .
Methods . We analyzed the data of 83 consecutive patients
(69 men, 14 women, aged 42 to 83 years [mean 66 .8]) with a left
ventricular ejection fraction !530% who underwent isolated cor-
onary artery bypass grafting (without aneurysmectomy, valve
replacement or other open heart procedures) performed by one
surgeon during a 6-year period . The ejection fraction ranged from
10% to 30% (mean 24 .6%). Preoperatively, 49% of patients had
angina, 52% had congestive heart failure (17% with pulmonary
edema) and 30% manifested significant ventricular arrhythmia .
The mean number of grafts was 2.7/patient . The internal mam-
mary artery was used in 82% of grafts to the left anterior
descending coronary artery . The intraaortic balloon pump was
required therapeutically (for angina or pump failure) in 19% of
patients and was prophylactically placed preoperatively in an-
other 43% of patients.
In patients with severe coronary artery disease, advanced
left ventricular dysfunction carries a poor long-term progno-
sis and increases the risk of coronary artery bypass grafting
(1-4). Despite the poor prognosis of advanced left ventricu-
lar dysfunction and severe coronary artery disease, there is
often reluctance to consider bypass grafting as a major or
early therapeutic option . Indeed, this operation has been
considered contraindicated in patients with a very low
ejection fraction (5) . The presumed high risk of operative
intervention and a concern that surgery cannot reverse an
already inexorable course have limited intervention by cor-
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Results . The hospital mortality rate was S .4% (7 of 3). The
mortality rate was 3.3% (2 of 61) in those patients who did not
require admission to an intensive care unit immediately before
operation. Canadian Cardiovascular Society angina class im .
proved postoperatively by 1 .9 categories and New York Heart
Association congestive heart failure class by I category . Left
ventricular ejection fraction (assessed postoperatively in 68 of 76
hospital survivors) improved from 24.6% preoperatively to 33.2%
postoperatively (36% increase) (p < 0 .001). At 1 and 3 „ :,r: : .,
respectively, all-causee survival was 87% and 80% and freedom
from cardiac death was 8%8% and 815% .
Conclusions . In patients with coronary artery disease and
advanced ventricular dysfunction : 1) coronary artery bypass
grafting can be performed relatively safely, 2) good medium-term
survival is attained, 3) improvement in left ventricular function
can be documented objectively after bypass grafting, 4) quality of
life is improved (as reflected by improvement in anginal and
congestive heart failure status), and 5) the internal mammary
artery can safely be used as a conduit . The use of coronary artery
bypass grafting is encouraged for this group of patients and may
provide a viable alternative to transplantation in selected patients .
(J Am Coil Cardiol 1993,22 .-1411-7)
onary artery bypass grafting in this setting . Another concern
is that graft patency might be compromised because of
inadequate runoff in patients with advanced ventricular
dysfunction and extensive myocardial scar . Consequently,
anginal relief might be disappointing (6) . For these reasons,
controversy still exists regarding the proper role of isolated
coronary bypass grafting in patients with severe left ventric-
ular dysfunction (7) .
Most large multicenter trials of coronary artery bypass
grafting have been confined to patients with relatively pre-
served ventricular function (ejection fraction >35% in the
Coronary Artery Surgery Study (CASS) (8) and ejection
fraction >50% in the European Coronary Surgery Study
Group [9]) .
Even among prior studies (10,11) in patients with
left ventricular dysfunction, the ejection fraction criterion
often chosen was too lenient to select out patients with
severely compromised ventricles
. The numbers of patients
with a low ejection fraction have often been small (only 12
0735-1097/93/56 .00
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patients with an ejection fraction <25% in one study [101) . In
some studies (10), patients undergoing mechanical correc-
tions such as valve replacement or aneurysmectomy in
addition to bypass grafting were not excluded from analysis,
although clearly the pathophysiology and mechanisms of
surgical benefit are different in these patients. In some prior
reports (10), no assessment of symptomatic state after graft-
ing was included, with emphasis only on survival .
For these reasons, the value of isolated coronary artery
bypass grafting for patients with advanced left ventricular
dysfunction and severe coronary artery disease is not clear .
This report is intended to address this issue by determining
the operative risk, long-term survival and symptomatic state
in patients with advanced left ventricular dysfunction under-
going coronary revascularization .
The last 6 years of isolated coronary artery bypass
grafting performed at our institution in patients with ad-
vanced left ventricular dysfunction is reviewed and both
operative and long-term survival and symptomatic state after
bypass grafting are reported . For the purposes of this study,
advanced left ventricular dysfunction is defined as ejection
fraction :93 . The review is confined to the consecutive
patients undergoing operation by one surgeon using a single,
standard operative technique . In view of the recent recogni-
tion of "stunned" and "hibernating" myocardium (12), a
comparison of left ventricular performance before and after
revascularization is reported,
Methods
Study patients, The study group consisted of 83 consec-
utive patients with an ejection fraction x30% undergoing
coronary artery bypass grafting (without other open heart
procedures) by one surgeon (J .A.E .) between January 1986
and June 1992 . Patients undergoing concomitant valve re-
placement or left ventricular aneurysmectomy were ex-
cluded from analysis . Age ranged from 42 to 83 years (mean
66;8). There were 69 men and 14 women (Table 1) .
Preoperative left ventricular ejection fraction was deter-
mined by contrast angiography in 38 patients and by equi-
librium radionuclide angiography in 45 (Fig . 1). Mean ejec-
tion fraction was 24 .6%, The lowest ejection fraction was
1 and the highest 30% . Postoperative ejection fraction
was determined in all cases by equilibrium radionuclide
angiography . A regression equation was used to normalize
preoperative contrast angiographic ejection fraction (EF) to
equilibrium radionuclide angiography (ERNA) scan equiva-
lents (13). This equation is as follows: ERNA EF = 0.86 x
ventriculographic EF + 2 .9. In the low range of ejection
fractions in this study, this formula changes the absolute
value of the ejection fraction between the two methods by
:S 1 . .
Six (7,5%) of 83 patients had a single coronary artery
bypass graft, 26 (31
.3%) had two grafts, 42 (50%) had three
grafts, 8 (9.6%) had four grafts and 1(1
.3%) had five grafts .
The mean number of grafts per patient was 2.7. Twenty-one
Table 1
. Clinical Characteristics of the 83 Study Patients
Unless otherwise indicated, values are expressed as number (%) . AICD
automatic implantable cardioverter .defibrillator
; IABP = intranortic balloon
pump ; MI = myocardial infarction .
patients (25%) underwent simultaneous placement of the
hardware for the automatic implantable cardioverter-
defibrillator because of an associated history of serious
ventricular arrhythmia . Sixty-three (76%) of 83 patients had
an internal mammary artery graft placed to the left anterior
descending coronary artery . Of the 77 patients who required
a graft to this artery, 63 (82%) had an internal mammary
artery graft . One patient had a sequential internal mammary
artery graft to two coronary arteries using the left internal
mammary artery . Sixteen patients (19%) had an intraaortic
balloon pump in place for therapeutic reasons (angina or low
output state) at the time of operation . In 36 patients (43%),
the intraaortic balloon pump was placed preoperatively for
prophylactic purposes to facilitate anesthesia and operation
and to protect the patient perioperatively .
Figure 1 . Frequency distribution graph of ejection fraction (EF) .
More than 50%a of the patients had an ejection fraction c25% . The
ejection fraction in the seven patients who died in the hospital were
13%, 18% . 20% (three patients), 26 and 30%, respectively .
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EF(%)
Age (yr)
Malelfemale
42 to 83 ; average 66 .8
69114
Ejection fraction (%) 10 to 30 ; mean 24.2
Grafts/patient (mean) 2 .7
Prior MI 62(75)
Associated AICD 21 (25)
IABP
Therapeutic
16(19)
Prophylactic
36(43)
Indications for surgery
Heart failure 43(52)
Pulmonary edema 1407)
Angina 41 (49)
Arrhythmia 21 (25)
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Indications for surgery were as follows . Forty-three pa-
tients (52%) had congestive heart failure, which was mani-
fested as pulmonary edema in 14 patients (17%) . Forty-one
patients (49%) had angina. Twenty-one patients (25%) re-
quired placement of an automatic implantable cardioverter-
defibrillator for treatment of ventricular arrhythmia and
underwent revascularization in conjunction with this proce-
dure. Twenty-two patients (27%) were acutely ill at the time
of revascularization and were in the intensive care unit for
treatment of ischemia or congestive heart failure (with 16 of
these 22 requiring intraaortic balloon pump support for
medical stabilization) . There was a history of known prior
myocardial infarction in 62 patients (75%) .
Operative technique. All patients underwent coronary
artery bypass grafting by a single surgeon using a standard
operative technique . Single cannulation of the right atrium
was carried out with a two-stage venous cannula . The left
ventricle was vented to gravity through the right superior
pulmonary vein. Myocardial preservation was performed by
means of systemic hypothermia (26° to 28'C , topical hypo-
thermia with iced saline solution and cold crystalloid car-
dioplegic solution administered into the ascending aorta
before each graft. Distal anastomoses were performed first
during a single period of aortic occlusion, with proximal
anastomoses performed subsequently under side-biting con-
trol of the ascending aorta .
Follow-up. Follow-up data were obtained from office
charts, hospital charts and interviews with the primary
physicians or the patient, or both . Complete follow-up data
were available in 80 (96 of 83 patients . Anginal status was
tabulated according to Canadian Cardiovascular Society
criteria and heart failure status by New York Heart Associ-
ation criteria .
Data analysis . Survival curves were dravmn on an actuar-
ial basis using the Kaplan-Meier technique . Survival curves
were compared by the Wilcoxon test . The statistical signif-
icance of differences was determined using the unpaired
t test (comparisons between patients with and without an
automatic implantable cardioverter-defibrillator and the
paired t test (comparison of pre- and postoperative ejection
fraction (Primer of Biostatistics : The Program, Version 3 .0,
McGraw-Hill .
Results
Surgical outcome . No patient died at operation . Nineteen
(23 of 83 patients required pharmacologic inotropic sup-
port in the operating room (usually low doses . Eleven of
these patients were already receiving such support when
brought to the operating room . There were seven in-hospital
deaths (8.4 . Five of the seven deaths were in patients who
had manifested cardiogenic shock from myocardial infarc-
tion earlier during the same hospital admission . Death oc-
curred on postoperative days 1, 4, 5, 6, 10, 11 and 14,
respectively . The cause of death was arrhythmia in two
patients, pump failure in two, cerebrovascular accident in
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Figure 2 . Actuarial survival,
with
the hospital mortality included .
Bars indicate standard errors ; numbers indicate patients reaching
each time point .
one, intestinal infarction in one and multiple organ failure in
one. One of the two patients dying from pump failure died of
end-stage right heart failure associated with antecedent fixed
high pulmonary vascular resistance .
No patient sustained a Q wave myocardial infarction or
subendocardial myocardial infarction by criteria used at our
hospital (creatine kinase, MB fraction LCK-MB] product
>90 IU/Iiter .
Among the 36 patients who had an intraaortic balloon
pump placed prophylactically, I had a vascular complication
requiring an operative thrombectomy . Among the 16 pa-
tients who had an intraaortic balloon pump placed therapeu-
tically, 2 had vascular complications ; I patient lost a limb
because of ischemia and the other required removal of the
balloon pump because of limb ischemia .
Follow-up. The duration of follow-up ranged from I to 62
months (mean 22 . During this period, nine patients died
outside the hospital at 2, 5, 8, 28, 29, 29, 38, 44 and 59
months, respectively . The cause of death was cardiac in four
(sudden death or heart failure
and noncardiac in five (cere-
brovascular accident, renal failure, diabetes, cancer
(Fig . 2 . In-hospital deaths are included in computing the
survival curve. Among all patients undergoing surgery,
survival was 87 at I year, 87
at 2 years and 80 at 3
years. The standard errors are indicated at the follow-up
points. Fifty-two patients attained a 1-year, 35 a 2-year and
17 a 3-year follow-up survival time .
Cardiac survival (freedom from death due to a cardiac
cause was 89 .8 at 1 year, 89 .8
at 2 years and 84 .5 at 3
years . (This tabulation includes all perioperative deaths as
cardiac and excludes only those late deaths clearly due to
noncardiac causes .
The 21 patients who underwent placement of the hard-
ware for an automatic implantable cardioverter-defibrillator
did not differ significantly in long-term survival (p = 0
.82 or
Aaml -
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Figure 3. Comparison of survival of patients with an ejection
fraction (EF of 10 to 20 with that of patients with an ejection
fraction of 21 to 3 i . There is no statistically significant difference
between the two curves (p = 0 .11 by Wilcoxon test .
in general characteristics from the 63 patients who did not
have this device implanted (0 women, 16.8 men, p =
0.17; mean age 68 .4 and 65.3 years, respectively, p = 0 .291 ;
preoperative ejection fraction : 23.9 and 24 .2 , respec-
tively, p = 0.742 .
Figure 3 compares the survival rate for the 21 patients
with an ejection fraction of 10 to 20 with that for the 62
patients with an ejection fraction of 21 to 300,'0. Although
the survival curve for the lower ejection fraction group
demonstrates a higher early mortality rate, the curve is flat,
so that at 3 years there is no statistically significant differ-
ence between the survival curves (p = 0 . 11, Wilcoxon test .
Figures 4 and 5 compare the preoperative and postoper-
ative symptomatic state . Follow-up data are recorded for all
patients alive and available
for follow-up study at the com-
pletion of data analysis, Patients with previous angina had
marked improvement : Nearly all were asymptomatic or
minimally symptomatic . Mean angina class (among patients
4. C in Canadian Cardiovascular Society angina status
after c artery bypass grafting . Mean angina category im-
proved from 3.2 to 1 .3 (p < 0
.01 by Wilcoxon signed-rank test for
ordinal data . Pre and Post = before and after bypass grafting,
respectively.
60
5o
40 -
30
20
10-
0
Pro Post
CHF Status
Figure 5. Change in New York Heart Association congestive heart
failure (CHF status after coronary artery bypass grafting . Mean
congestive heart failure category improved from 2 .8 to 1 .8 (p < 0 .01
by Wilcoxon signed-rank test for ordinal data . Abbreviations as in
Figure 4 .
with angina improved from 3 .2 preoperatively to 1 .3 post-
operatively. Improvement in congestive heart failure status
was realized as well, with the majority of patients in class I
or II after operation. Mean congestive heart failure class
(among patients with congestive heart failure improved
from 2.8 preoperatively to 1 .8 postoperatively .
Figure 6 presents the pre- and postoperative ejection
fraction data. Sixty-eight (89.5 of the 76 hospital survivors
underwent follow-up equilibrium radionuclide angiography
studies after operation . gjection fraction was determined at
a mean of 6.2 months from coronary artery bypass grafting
(range 7 days to 39 months . Mean ejection fraction in-
creased substantially from 24 .6 to 33 .2 (p < 0.001 . Only
five patients showed a decrease of >4 ejection fraction
percentage points, with the remainder showing no change
(21 patients with an ejection fraction within 4 ejection
fraction points of that before operation or improving
(42 patients . The maximal improvement was 29 ejection
fraction units (from 30 to 59 .
Comparison of results between the 22 critically ill patients
Figure 6. Change in ejection fraction after coronary artery bypass
grafting (improvement in mean ejection fraction was significant at
the level of p < 0 .001 by paired t test . Pre-op and Post-op = before
and after coronary artery bypass grafting, respectively .
I
11
III
I
Post-op
meu 33.2
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in the intensive care unit immediately before operation and
the 61 patients not in the intensive care unit revealed the
following: The hospital mortality rate was higher in patients
in the intensive care unit (217 [5 of 22] vs . 3 .3 [2 of 61
(p ® 0.004 by mest . Improvement in ejection fraction after
coronary artery bypass grafting did not differ significantly
between patients in or not in the intensive care unit preop-
eratively (6 .5 vs. 8.9 , p = 0.40 by t test . Long-term
survival also did not differ between the two groups (81 ® and
7996, respectively, at 3 years, p = 0 .36 by Wilcoxon test .
Only 15 preoperative thallium or sestamibi myocardial
perfusion imaging studies had been performed at Yale-New
Haven Hospital within 6 months of coronary artery bypass
grafting . Ten studies were performed with stress testing
(seven by treadmill and three with dipyridamole ; five stud-
ies were performed only at rest . All patients showed fixed
defects consistent with scar . Nine patients were also found
to have areas of reversible defects consistent with viability
or ischemia . After bypass grafting, absolute ejection fraction
increased by 7 .6 in the patients who showed reversibility
and 11 .5 in the patients who did not. This difference was
not significant statistically (p = 0.48 by t test ; however, the
sample size does not provide sufficient power for analysis .
Discussion
Although coronary artery bypass grafting in the setting of
a very low ejection fraction remains controversial (5-7,14-
23 , the present study strongly supports its application . A
unifying concept behind our findings is that coronary artery
bypass grafting preserves already functioning muscle against
future infarction and recruits hibernating muscle (12 . This
recruitment leads to the objective improvement in ejection
fraction and to the amelioration of congestive heart failure .
The protection against infarction results in enhanced
medium-term survival .
Conclusions . We emphasize the following specific con-
clusions to our study .
Safety of operation . The 8.4 hospital mortality rate
indicates that even those patients with marked left ventric-
ular compromise can undergo bypass surgery relatively
safely. The majority of in-hospital deaths (five of seven
occurred in patients manifesting postinfarction cardiogenic
shock at the time of operation or earlier during the same
hospital admission. This implies that for patients in stable
condition with severe ventricular dysfunction, coronary
artery bypass grafting may be even safer than is reflected in
the overall statistics .
Long-term survival . Long-term survival (87 at 1 year
and 80 at 3 years is excellent in the context of expected
medical prognosis . These results include hospital deaths
after coronary artery bypass grafting
. The survival rate for
patients discharged from the hospital is 96 at 1 year and
88 at 3 years. These results are consistent with the best
results reported from recent work despite our relatively
severe ejection fraction criterion of s30 (as opposed to the
1415
35 to 40 ejection fraction criteria used in certain other
studies (3, 10, 16, 17, 19, 20 . It is worth emphasizing that in
our study . once patients with severe ventrlc°ulcer impairment
underwent coronary artery bypass grafting and survived to
leave the hospital, they did exceptionally well . Even those
patients with an ejection fraction s20 17o manifested good
long-term survival after bypass grafting .
Improvement in ventricular function . Improvement in
left ventricular function after coronary artery bypass grafting
was objectively demonstrated . The mean ejection fraction
was 24 .6 before bypass grafting and 33 .2 after grafting.
This degree of change is not only statistically significant, but
also large enough to be of physiologic and clinical relevance .
Almost no patients manifested a decrease in ejection frac-
tion . The 8.6 percentage point change in ejection fraction
represents a 361/1c change above baseline values . We consider
this improvement in ejection fraction as evidence that func-
tion was restored by provision of blood flow tt previously
dysfunctional regions of ischemic or hibernating myocar-
dium .
Quality of life . We also found dramatic improvement in
both anginal status and congestive heart failure status .
Angina was almost uniformly abolished . Congestive heart
failure was lessened . These results would contradict prior
recommendations (10,17-22 that the absence of angina or
the presence of congestive heart failure should mitigate
against coronary artery bypass grafting in patients with
advanced left ventricular dysfunction. Even though 51 of
our patients were angina-free and 52 had congestive heart
failure, the operative mortality rate was not excessive,
medium-term survival was very good and congestive heart
failure status improved after bypass grafting .
Use of the internal mammary artery conduit . Poor ven-
tricular function has been considered a contraindication to
use of the internal mammary artery (24 . With one exception
(23 , all prior reports reviewed did not refer to or use the
internal mammary artery conduit
. The concern has been that
compared with a saphenous vein graft, this artery may not
provide as much early flow and may be more susceptible to
spasm, especially with inotropic support . We used the
internal mammary artery almost routinely in patients requir-
ing left anterior descending coronary artery revasculariza-
tion (82 of these patients
. No problems referable to this
use were apparent . It is possible that the known long-term
patency advantages of the internal mammary artery graft
may contribute to the longevity of some of the patients in our
study. On thz basis of our data, we recommend use of the
internal mammary conduit in such patients .
Our data support the use of the intraaortic balloon pump,
which appeared to play a relevant role in rendering coronary
artery bypass grafting safe in patients with marked impair-
ment of ventricular function
. In contradistinction to support
with inotropic agents, the intraaortic balloon pump augments
myocardial performance without increasing the workload on
the heart and myocardial oxygen requirements (25 . The
balloon pump has been used frequently in nearly all prior
JACC Vol. 22, No . 5
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studies of coronary artery bypass grafting in patients with a
low ejection fraction, but often on an as needed
basis
intraoperatively when attempting to wean the patient from
cardiopulmonary bypass
. In contrast, selective prophylactic
use (our selection was subjective, based on severity of
depression of ventricular function and vulnerability of coro-
nary supply
avoids the cardiac distension and oxygen debt
incurred before the decision for ad hoc use at the time of
attempted weaning from cardiopulmonary bypass . Postoper-
ative inotropic support was required relatively infrequently
(23 of cases in our study, supporting the view that the
intraaortic balloon pump was of value . Avoidance of peri-
operative myocardial damage through use of the balloon
pump may have been a factor allowing the emergence of the
net improvement of ejection fraction seen in our patients .
Complications from prophylactic balloon pump use were
infrequent and manageable .
Twenty-one of our patients underwent associated place-
ment of an automatic implantable cardioverter-defibrillator
because of prior life-threatening ventricular tachycardia
or ventricular fibrillation . Patients with severe arrhythmia
were often excluded in prior investigations, most of which
were done before the advent of the automatic implantable
cardioverter-defibrillator . The presence of this device in a
portion of our cohort may have contributed to long-term
survival. Both the preoperative clinical states and subse-
quent outcome were comparable in those with and without
automatic implantable cardioverter-defibrillator placement .
There is clearly an overlap between the patients included
in the present report and those evaluated for heart transplan-
tation for ischemic cardiomyopathy . The safety of operation,
improvement in symptomatic state, objective improvement
in left ventricular ejection fraction and good medium-term
survival realized in the present series argue for consideration
of coronary artery bypass grafting as an alternative to
transplantation in selected patients,
In the present stt' .iy, the postoperative equilibrium radio-
nuclide angio p hic evaluations were obtained at varying
intervals after coronary artery bypass grafting . Conse-
quently, physiologic factors that may have influenced the
ejection fraction (such as blood pressure control and nega-
tive inotropic medications were not controlled at the times
of pre- and postoperative ejection fraction determinations .
In early postoperative studies, stunning may still have been
present, Despite these factors, the improvement in ejection
fraction is both statistically meaningful and physiologically
relevant, Further standardization and control of intervening
factors in future studies may magnify even further the
objective postoperative improvement in ventricular function
in appropriately selected patients .
These patients were enlisted primarily without a detailed
assessment of myocardial viability by means of perfusion
scintigraphy with delayed thallium imaging or positron
emission tomography (2o-29 . Such studies, which should
be employed prospectively in the present era, could further
enhance selection of patients for coronary artery bypass
grafting in the setting of substantial ventricular dysfunction .
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